RT @DryAMD: RT @YoungRetina: Should we consider off-label AREDS2 supplementation for MacTel type 2? This retrospective study shares single-…
1,056 followers
13 followers
RT @YoungRetina: Should we consider off-label AREDS2 supplementation for MacTel type 2? This retrospective study shares single-center experience https://t.co/Jj323pPDxu #retina #ophthalmology #macularteleangiectasia https://t.co/eGrkf8mK27
1,056 followers
RT @YoungRetina: Should we consider off-label AREDS2 supplementation for MacTel type 2? This retrospective study shares single-center exper…
2,080 followers
Should we consider off-label AREDS2 supplementation for MacTel type 2? This retrospective study shares single-center experience https://t.co/SrfX9NqxMo #retina #ophthalmology #macularteleangiectasia https://t.co/W9jHI1kJTb